Actively Recruiting
Life-2023-02 Esophagogastric Variceal Bleeding
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2023-08-25
33
Participants Needed
1
Research Sites
157 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Study on the efficacy of the growth inhibitors after endoscopic treatment of acute esophagogastric variceal bleeding
CONDITIONS
Official Title
Life-2023-02 Esophagogastric Variceal Bleeding
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Acute esophagogastric bleeding with hepatic cirrhosis
- Stable status with no active bleeding
- Age between 18 and 70 years
You will not qualify if you...
- Limitations for endoscopic testing
- History of previous acute esophagogastric variceal bleeding treatment
- Current admission to intensive care unit (ICU)
- Pregnancy
- Immunity disabled
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hanzhou, Zhejiang, China, 310000
Actively Recruiting
Research Team
W
WEI WEI
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here